Forefront Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.27M Sell
3,869
-83
-2% -$26.3K 0.91% 33
2025
Q3
$1.12M Sell
3,952
-144
-4% -$41.8K 0.82% 35
2025
Q2
$1.14M Sell
4,096
-30
-0.7% -$8.5K 0.92% 33
2025
Q1
$1.29M Buy
4,126
+130
+3% +$38.4K 1.19% 30
2024
Q4
$1.04M Buy
+3,996
New +$1.19M 0.96% 28

Other funds holding AMGN

Forefront Wealth Management's AMGN Position: Q4 2025 in Review

Forefront Wealth Management reduced its Amgen (AMGN) stake by 2.1% in Q4 2025, selling an estimated $26.3K and leaving 3,869 shares worth $1.27M. The position accounts for 0.91% of the portfolio, ranked #33.

Forefront Wealth Management first reported a position in AMGN in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.29M in Q1 2025. 3,093 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Forefront Wealth Management held 3,869 shares of Amgen worth $1.27M as of Q4 2025.
  • Forefront Wealth Management sold 83 Amgen shares in Q4 2025, an estimated $26.3K.
  • Amgen made up 0.91% of Forefront Wealth Management's portfolio in Q4 2025, its #33 holding.
  • Forefront Wealth Management first reported a position in Amgen in Q4 2024 and has held it in 5 quarters since.
  • Forefront Wealth Management's Amgen position peaked at $1.29M in Q1 2025.
  • 3,093 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Forefront Wealth Management's 13F filing for Q4 2025, filed 23 Jan 2026.